Liriodendrin

Description: Liriodendrin regulates lung inflammation, the phosphorylation of the NF-kB (p65) and expression of vascular endothelial growth factor (VEGF). Liriodendrin has anti-inflammatory, antinociceptive, hypoglycemic activities and plays protective role in sepsis-. Target: Potassium Channel, Prostaglandin Receptor, ATPase. Smiles: COc1cc([C@H]2OC[C@@H]3[C@@H](c(cc4OC)cc(OC)c4O[C@@H]([C@@H]([C@H]4O)O)O[C@H](CO)[C@H]4O)OC[C@@H]23)cc(OC)c1O[C@@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O. References: Metabolism of liriodendrin and syringin by human intestinal bacteria and their relation to in vitro cytotoxicity.Arch Pharm Res. 1999 Feb,22(1):30-4.